Qventus Raises $105M in Series D Funding to Expand AI-Based Care Automation
Qventus focuses on addressing health system pain points with its AI-driven platform.
Company Name: Qventus
Location: New York City, NY
Industry: Health tech
Funding Details:
Amount: $105M (Series D)
Investors: KKR (Lead), Bessemer Venture Partners, Northwestern Medicine, HonorHealth, Allina Health
Purpose of Investment:
The funds will be used to:
- Accelerate the development of AI Operational Assistants.
- Expand solutions into new care settings beyond Surgical Growth and Inpatient Capacity.
Leadership:
CEO: Mudit Garg
Product:
Qventus provides AI-powered software solutions that optimize care operations in operating rooms (OR) and inpatient settings. Key features include:
- AI Operational Assistants: Automate care operations to improve efficiency and reduce cognitive load on care teams.
- EHR Integration: Leverages GenerativeAI, machine learning, and behavioral science to predict bottlenecks, recommend remedies, and automate workflows.
Impact:
- Inpatient Solution: Eliminated over 36,000 excess inpatient days in the past year, saving millions and increasing capacity for patient care.
- Perioperative Solution: Generated $95M in annualized contribution margin for hospitals in 2024 by enabling additional surgical volume.
About the Company:
Qventus focuses on addressing health system pain points with its AI-driven platform. By enhancing patient flow and automating care operations, it empowers health systems to improve outcomes, reduce costs, and serve more patients effectively.
With its Series D funding, Qventus is positioned to expand its reach and further transform care delivery across diverse healthcare settings.
